Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FKEGA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,012
Award facts
- Contract value 100% obligated
- $26,011.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $26,011.96 by the Defense Logistics Agency (DLA) on May 20, 2025. The delivery order, which is not subject to a set-aside designation, covers the supply of Tecentriq 1,200 mg/20 ml vials for delivery to Park Ridge, Illinois, with an ultimate completion date of June 11, 2025. This award represents a specific pharmaceutical fulfillment issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and extending through November 2026.
DMS Pharmaceutical Group leverages its established position as a critical supplier within the federal pharmaceutical supply chain to fulfill oncology and specialty medication needs for Department of Defense healthcare facilities. The delivery order for Tecentriq, a branded immunotherapy product, demonstrates the company's capability to provide specialized pharmaceutical products supporting military health system requirements. As a consistent contractor with the DLA across multiple pharmaceutical product categories, DMS Pharmaceutical Group continues to supply essential medications and biologics to federal healthcare infrastructure nationwide through its comprehensive SPE2DB vehicle.
Quick answers
Who was awarded contract SPE2DB25FKEGA?
SPE2DB25FKEGA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 20, 2025.
How much is contract SPE2DB25FKEGA worth?
The government has obligated $26,012 on SPE2DB25FKEGA.
Is contract SPE2DB25FKEGA an order under another contract?
Yes. SPE2DB25FKEGA is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEGA competed?
The extent of competition for SPE2DB25FKEGA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award